[Federal Register Volume 63, Number 128 (Monday, July 6, 1998)]
[Notices]
[Pages 36410-36411]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17766]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[30DAY-17-98]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7090. Send written 
comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
Executive Office Building, Room 10235; Washington, DC 20503. Written 
comments should be received within 30 days of this notice.

Proposed Projects

    1. Project Intensive Care Antimicrobial Resistance Epidemiology 
(ICARE), Phase 3--Reinstatement--The Hospital Infections Program, 
National Center for Infectious Diseases, Centers for Disease Control 
and Prevention, is proposing a study to investigate the relationship 
between use of antimicrobial agents and the incidence of antimicrobial 
resistance at 40 U.S. hospitals. The proposed Phase 3 study of Project 
ICARE will be very similar to Phase 2 ICARE with minor revisions. We 
hope to enroll 40 hospitals and address many confounding factors of 
antimicrobial resistance. In addition, these hospitals will serve as a 
sentinel surveillance system for different antimicrobial resistant 
pathogens, such as vancomycin resistant staphylococci. About half of 
the hospitals have participated in Phase 2 of Project ICARE. 
Participating hospitals will all be active participants of the CDC's 
National Nosocomial Infections Surveillance (NNIS) system. Phase 3 of 
Project ICARE is a refinement of the Phase 2 study and will allow 
interhospital comparison of data (i.e., sending interim reports back to 
study hospitals) facilitated by incorporating differences in culturing 
frequency, case-mix by ICU type and speciality wards (i.e., internal 
organization), barrier precautions, and prescribing practice policies. 
Phase 3 will also allow for valid comparison of attempts at reducing 
antimicrobial resistance in study hospitals (i.e., publish results of 
interventions to reduce antimicrobials resistance at study hospitals). 
Also, key parameters of antimicrobial use could be correlated with 
antimicrobial resistance levels and tracked through the hospital's 
quality improvement indicator process, pharmacy and therapeutics 
committee, or medical staff. Unnecessary use of antimicrobials may be 
reduced by these efforts if the information can be provided to 
hospitals. The total annual burden hours are 6,160.

----------------------------------------------------------------------------------------------------------------
                                                                                   Avg. burden/                 
             Form name                  Number of      No. responses/respondent    response (in    Total burden 
                                       respondents                                     hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Primary contact....................              40  12                                     1                480
Pharmacy...........................              40  48 (median)                            2.0            3,840
Microbiology.......................              40  60 (median)                            0.5            1,200
Isolates...........................              40  80 (maximum)                           0.20             640
----------------------------------------------------------------------------------------------------------------

    2. 1999 and 2001 National School-Based Youth Risk Behavior 
Surveys--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP)--Reinstatement--The purpose of this request is to 
renew OMB clearance for a biennial, national, youth risk behavior 
survey. This ongoing biennial survey is administered to students 
attending regular public, private, and Catholic schools in grades 9-12. 
The survey addresses priority health risk behaviors related to the 
major preventable causes of mortality, morbidity, and social problems 
among both youth and adults in the U.S. Previous OMB clearance for 
these surveys expired in October of 1997 (OMB No. 1920-0258, expiration 
10/97). OMB clearance for a similar survey conducted among alternative 
school students will expire in December of 1998 (OMB No. 0920-0416, 
expiration 12/31/98). Data on the health risk

[[Page 36411]]

behaviors of adolescents is the focus of at least 26 national health 
objectives in Healthy People 2000: Midcourse Review and 1995 Revisions. 
This survey will provide end-of-decade data to help measure these 
objectives, as well as baseline data to measure many new national 
health objectives proposed for 2010. No other national source of data 
exists for most of the proposed 2010 objectives that address behaviors 
of adolescents. The data also will have significant implications for 
policy and program development for school health programs nationwide. 
The total annual burden hours are 9,173.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. burden/                 
                   Respondents                       Number of      responses/     response (in    Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Alternative school students.....................          12,000               1            0.75           9,000
Educating officials.............................             345               1            0.50             173
----------------------------------------------------------------------------------------------------------------

    Dated: June 26, 1998.
Charles Gollmar,
Acting Associate Director for Policy Planning and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 98-17766 Filed 7-2-98; 8:45 am]
BILLING CODE 4163-18-P